NanoVation Therapeutics
PrivateLast Round
Seed
Nov 19, 2024
Total Funding Raised
$219,000
Company Overview
NanoVation Therapeutics operates in Healthcare & Life Sciences and is based in Vancouver, British Columbia. Its latest recorded funding round was a Seed round in November 2024.
NanoVation Therapeutics is a biotechnology company that develops a lipid nanoparticle (LNP) platform for nucleic acid delivery to enable genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoVation Therapeutics Comparables
Compare NanoVation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevant Sciences | 88% | |
| Acuitas Therapeutics | 85% | |
| Kamal Therapeutics, Inc. | 85% |
For institutional investors. Book with your work email.
NanoVation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2024 | ||||
| Grant | Sep 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoVation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate BC | Grant |
| Convergent Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Monthly visitors increased 48% MoM.
- Jan 2, 2026
Monthly visitors grew 106% MoM, reaching 4.6K.
For institutional investors. Book with your work email.
NanoVation Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoVation Therapeutics's valuation, stock price, and market status.
Is NanoVation Therapeutics a public or private company?
NanoVation Therapeutics is a private company.
What is the current stock price of NanoVation Therapeutics?
NanoVation Therapeutics is a private company, so its shares have no public market price. Caplight tracks NanoVation Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoVation Therapeutics worth (valuation)?
Valuation information for NanoVation Therapeutics is not publicly available.
Can I buy NanoVation Therapeutics stock?
NanoVation Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoVation Therapeutics's last funding round?
NanoVation Therapeutics's most recent funding round was Seed on November 19, 2024.
Who are the main investors in NanoVation Therapeutics?
Key investors in NanoVation Therapeutics include Convergent Ventures.
Will NanoVation Therapeutics IPO soon?
No public IPO plans have been announced for NanoVation Therapeutics.
How can I track NanoVation Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NanoVation Therapeutics's shares on secondary markets.